Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sublingual vs oral captopril in hypertensive patients
IRCT2015110924963N1Phase 3Completed
- Sponsor
- Shahrood Islamic Azad University
- Start
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of captopril in hypertension (HTN) (2 arms), sponsored by Shahrood Islamic Azad University. Primary endpoints: Efficacy in blood pressure control and Patient satisfaction. Started Dec 2015; status: completed.
02
Drugs
captopril
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on IRCT2015110924963N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2015110924963N1.